Epithelial-mesenchymal transition (EMT) in kidney fibrosis: fact or fantasy?
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 21370523.
- Also identified by PMC identifier 3026733.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Epithelial-mesenchymal transition (EMT) has become widely accepted as a mechanism by which injured renal tubular cells transform into mesenchymal cells that contribute to the development of fibrosis in chronic renal failure. However, an increasing number of studies raise doubts about the existence of this process in vivo. Herein, we review and summarize both sides of this debate, but it is our view that unequivocal evidence supporting EMT as an in vivo process in kidney fibrosis is lacking.
Medical subject headings
- Epithelial-Mesenchymal Transition
- Kidney
- Kidney Diseases